应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ALT Altimmune, Inc.
盘后交易 04-22 19:00:51 EDT
4.85
+0.06
+1.25%
盘后
4.90
+0.05
+1.01%
18:52 EDT
最高
4.94
最低
4.71
成交量
180.67万
今开
4.88
昨收
4.79
日振幅
4.76%
总市值
3.74亿
流通市值
3.70亿
总股本
7,701万
成交额
866.99万
换手率
2.37%
流通股本
7,634万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Altimmune, Inc.盘中异动 急速拉升5.16%报4.79美元
市场透视 · 04-21 22:32
Altimmune, Inc.盘中异动 急速拉升5.16%报4.79美元
Altimmune, Inc.盘中异动 下午盘股价大涨5.05%报4.37美元
市场透视 · 04-12
Altimmune, Inc.盘中异动 下午盘股价大涨5.05%报4.37美元
Altimmune, Inc.盘中异动 下午盘急速跳水5.12%报5.29美元
市场透视 · 03-11
Altimmune, Inc.盘中异动 下午盘急速跳水5.12%报5.29美元
Altimmune, Inc.2024财年实现净利润-95.06百万美元,同比减少7.47%
市场透视 · 03-08
Altimmune, Inc.2024财年实现净利润-95.06百万美元,同比减少7.47%
Altimmune, Inc.盘中异动 股价大跌5.07%
市场透视 · 03-07
Altimmune, Inc.盘中异动 股价大跌5.07%
HC Wainwright & Co.:重申Altimmune(ALT.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。
金融界 · 03-04
HC Wainwright & Co.:重申Altimmune(ALT.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。
Altimmune, Inc.盘中异动 股价大跌5.04%
市场透视 · 03-03
Altimmune, Inc.盘中异动 股价大跌5.04%
Altimmune, Inc.盘中异动 早盘股价大涨6.06%
市场透视 · 02-27
Altimmune, Inc.盘中异动 早盘股价大涨6.06%
Altimmune 2024年第四季度GAAP每股收益为$(0.33),符合预期,收入同比下降至$5.00千,现金及短期投资$131.9百万
财报速递 · 02-27
Altimmune 2024年第四季度GAAP每股收益为$(0.33),符合预期,收入同比下降至$5.00千,现金及短期投资$131.9百万
Altimmune, Inc.盘中异动 股价大跌5.07%报5.80美元
市场透视 · 02-26
Altimmune, Inc.盘中异动 股价大跌5.07%报5.80美元
Altimmune, Inc.盘中异动 快速跳水5.02%
市场透视 · 02-24
Altimmune, Inc.盘中异动 快速跳水5.02%
Altimmune, Inc.盘中异动 大幅拉升5.02%报6.69美元
市场透视 · 02-19
Altimmune, Inc.盘中异动 大幅拉升5.02%报6.69美元
Altimmune, Inc.盘中异动 早盘股价大跌5.29%
市场透视 · 02-11
Altimmune, Inc.盘中异动 早盘股价大跌5.29%
疑似AltLayer新多签地址从CEX提取3.99亿枚ALT,约合1982万美元
金色财经 · 02-06
疑似AltLayer新多签地址从CEX提取3.99亿枚ALT,约合1982万美元
Altimmune, Inc.盘中异动 股价大涨5.12%报6.98美元
市场透视 · 02-05
Altimmune, Inc.盘中异动 股价大涨5.12%报6.98美元
Altimmune, Inc.盘中异动 早盘急速下跌5.42%报6.28美元
市场透视 · 02-03
Altimmune, Inc.盘中异动 早盘急速下跌5.42%报6.28美元
Altimmune, Inc.盘中异动 下午盘股价大跌5.00%
市场透视 · 02-01
Altimmune, Inc.盘中异动 下午盘股价大跌5.00%
Altimmune, Inc.盘中异动 早盘股价大涨6.18%
市场透视 · 01-15
Altimmune, Inc.盘中异动 早盘股价大涨6.18%
Altimmune, Inc.盘中异动 早盘股价大跌5.01%
市场透视 · 01-14
Altimmune, Inc.盘中异动 早盘股价大跌5.01%
Altimmune, Inc.盘中异动 早盘股价大跌5.03%报7.08美元
市场透视 · 01-10
Altimmune, Inc.盘中异动 早盘股价大跌5.03%报7.08美元
加载更多
公司概况
公司名称:
Altimmune, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Altimmune, Inc.于2005年4月25日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司,专注于开发肥胖和肝脏疾病的治疗方法。公司的主要候选产品pemvidutide(原名ALT-801)是一种GLP-1/胰高血糖素双受体激动剂,正在开发用于治疗肥胖和代谢功能障碍相关的脂肪性肝炎(“MASH”),以前称为非酒精性脂肪性肝炎(“NASH”)。
发行价格:
--
{"stockData":{"symbol":"ALT","market":"US","secType":"STK","nameCN":"Altimmune, Inc.","latestPrice":4.85,"timestamp":1745352000000,"preClose":4.79,"halted":0,"volume":1806695,"hourTrading":{"tag":"盘后","latestPrice":4.8988,"preClose":4.85,"latestTime":"18:52 EDT","volume":35664,"amount":173169.46931520003,"timestamp":1745362364902},"delay":0,"floatShares":76335159,"shares":77013658,"eps":-1.338795,"marketStatus":"盘后交易","change":0.06,"latestTime":"04-22 19:00:51 EDT","open":4.88,"high":4.938,"low":4.71,"amount":8669932.554778,"amplitude":0.047599,"askPrice":4.94,"askSize":30,"bidPrice":4.85,"bidSize":54,"shortable":3,"etf":0,"ttmEps":-1.338795,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.79,"preHourTrading":{"tag":"盘前","latestPrice":4.84,"preClose":4.79,"latestTime":"09:20 EDT","volume":3953,"amount":19255.292274,"timestamp":1745328054566},"postHourTrading":{"tag":"盘后","latestPrice":4.8988,"preClose":4.85,"latestTime":"18:52 EDT","volume":35664,"amount":173169.46931520003,"timestamp":1745362364902},"volumeRatio":1.008634,"impliedVol":1.1726,"impliedVolPercentile":0.62},"requestUrl":"/m/hq/s/ALT","defaultTab":"news","newsList":[{"id":"2529383675","title":"Altimmune, Inc.盘中异动 急速拉升5.16%报4.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529383675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529383675?lang=zh_cn&edition=full","pubTime":"2025-04-21 22:32","pubTimestamp":1745245959,"startTime":"0","endTime":"0","summary":"北京时间2025年04月21日22时32分,Altimmune, Inc.股票出现波动,股价急速上涨5.16%。截至发稿,该股报4.79美元/股,成交量42.2259万股,换手率0.55%,振幅8.13%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.04%。其相关个股中,Ocean Biomedical Inc C/Wts 14/02/2028 、Aptevo Therapeutics Inc.、Dogwood Therapeutics, Inc.涨幅较大,Aptevo Therapeutics Inc.、Transcode Therapeutics, Inc.、Dogwood Therapeutics, Inc.较为活跃,换手率分别为1074.80%、907.52%、739.63%,振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Dogwood Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ,振幅分别为106.34%、58.81%、43.24%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421223239aa2c7467&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250421223239aa2c7467&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","BK4139","LU1878469433.USD","BK4599"],"gpt_icon":0},{"id":"2526861922","title":"Altimmune, Inc.盘中异动 下午盘股价大涨5.05%报4.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526861922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526861922?lang=zh_cn&edition=full","pubTime":"2025-04-12 01:53","pubTimestamp":1744394027,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时53分,Altimmune, Inc.股票出现异动,股价大幅拉升5.05%。截至发稿,该股报4.37美元/股,成交量76.3477万股,换手率0.99%,振幅5.89%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为1.87%。其相关个股中,Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大,Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.、Conduit Pharmaceuticals Inc.较为活跃,换手率分别为2122.14%、1676.89%、400.18%,振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.,振幅分别为193.75%、156.27%、77.44%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412015347a6b8083f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412015347a6b8083f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","ALT","BK4599","BK4139"],"gpt_icon":0},{"id":"2518682201","title":"Altimmune, Inc.盘中异动 下午盘急速跳水5.12%报5.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518682201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518682201?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:21","pubTimestamp":1741630882,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时21分,Altimmune, Inc.股票出现波动,股价大幅跳水5.12%。截至发稿,该股报5.29美元/股,成交量148.018万股,换手率1.92%,振幅4.90%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.70%。其相关个股中,Mineralys Therapeutics, Inc.、Aeon Biopharma, Inc.、Checkpoint Therapeutics, Inc.涨幅较大,Aeon Biopharma, Inc.、Biodexa Pharmaceuticals Plc、Scisparc Ltd.较为活跃,换手率分别为5934.70%、3845.43%、1003.65%,振幅较大的相关个股有Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Biodexa Pharmaceuticals Plc,振幅分别为90.44%、88.14%、59.34%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102212298a2d5af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102212298a2d5af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","ALT","LU1878469433.USD","BK4139"],"gpt_icon":0},{"id":"2517430971","title":"Altimmune, Inc.2024财年实现净利润-95.06百万美元,同比减少7.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517430971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517430971?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363235,"startTime":"0","endTime":"0","summary":"3月8日,Altimmune, Inc.公布财报,公告显示公司2024财年净利润为-95.06百万美元,同比减少7.47%;其中营业收入为20000.00美元,同比减少95.31%,每股基本收益为-1.34美元。从资产负债表来看,Altimmune, Inc.总负债15.80百万美元,其中短期债务279000.00美元,资产负债比为0.09,流动比率为0.14。机构评级:截至2025年3月8日,当前有8家机构对Altimmune, Inc.目标价做出预测,其中目标均价为22.38美元,其中最低目标价为12.00美元,最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000046a2647e59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000046a2647e59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT"],"gpt_icon":0},{"id":"2517319420","title":"Altimmune, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517319420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517319420?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:05","pubTimestamp":1741287928,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时05分,Altimmune, Inc.股票出现波动,股价大幅下挫5.07%。Altimmune, Inc.股票所在的生物技术行业中,整体跌幅为0.84%。其相关个股中,Plus Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大,Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为4920.76%、3757.89%、255.79%,振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.,振幅分别为125.28%、122.63%、71.44%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307030529963c7cb5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307030529963c7cb5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALT","LU1878469433.USD","BK4599"],"gpt_icon":0},{"id":"2516651619","title":"HC Wainwright & Co.:重申Altimmune(ALT.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516651619","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516651619?lang=zh_cn&edition=full","pubTime":"2025-03-04 01:55","pubTimestamp":1741024555,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.:重申Altimmune(ALT.US)评级,由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04015548498807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ALT"],"gpt_icon":0},{"id":"2516580806","title":"Altimmune, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516580806","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516580806?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:53","pubTimestamp":1741017238,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时53分,Altimmune, Inc.股票出现波动,股价急速下挫5.04%。截至发稿,该股报6.32美元/股,成交量54.6719万股,换手率0.77%,振幅5.19%。Altimmune, Inc.股票所在的生物技术行业中,整体跌幅为0.38%。其相关个股中,Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Radiopharm Theranostics Limited涨幅较大,Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃,换手率分别为2916.94%、141.90%、133.69%,振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.,振幅分别为206.20%、70.53%、50.09%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032353589637c135&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032353589637c135&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","BK4599","BK4139","LU1878469433.USD"],"gpt_icon":0},{"id":"2514385796","title":"Altimmune, Inc.盘中异动 早盘股价大涨6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514385796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514385796?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:35","pubTimestamp":1740666911,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时35分,Altimmune, Inc.股票出现波动,股价快速上涨6.06%。截至发稿,该股报6.30美元/股,成交量22.7561万股,换手率0.32%,振幅4.55%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.45%。其相关个股中,Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Alector, Inc.涨幅较大,Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃,换手率分别为430.02%、92.85%、67.12%,振幅较大的相关个股有Channel Therapeutics Corporation、Quoin Pharmaceuticals Ltd、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ,振幅分别为16.42%、15.14%、14.83%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223511abdf6f9a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223511abdf6f9a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","LU1878469433.USD","BK4139","BK4599"],"gpt_icon":0},{"id":"1127825329","title":"Altimmune 2024年第四季度GAAP每股收益为$(0.33),符合预期,收入同比下降至$5.00千,现金及短期投资$131.9百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1127825329","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127825329?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:07","pubTimestamp":1740658067,"startTime":"0","endTime":"0","summary":"Altimmune报告2024年第四季度每股亏损为$,符合分析师的共识预期。公司本季度报告收入为$5.00千,与去年同期的$37.00千相比下降了86.49%。以上内容来自Benzinga Earnings专栏,原文如下:Altimmune reported quarterly losses of $ per share which met the analyst consensus estimate. This is a 38.89 percent increase over losses of $ per share from the same period last year. The company reported $5.00 thousand in sales this quarter. This is a 86.49 percent decrease over sales of $37.00 thousand the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Altimmune 2024年第四季度GAAP每股收益为$(0.33),符合预期,收入同比下降至$5.00千,现金及短期投资$131.9百万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALT"],"gpt_icon":0},{"id":"2514148800","title":"Altimmune, Inc.盘中异动 股价大跌5.07%报5.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514148800","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514148800?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:32","pubTimestamp":1740501166,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时32分,Altimmune, Inc.股票出现异动,股价急速下跌5.07%。截至发稿,该股报5.80美元/股,成交量100.272万股,换手率1.41%,振幅6.87%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.21%。其相关个股中,Organovo Holdings, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp涨幅较大,Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃,换手率分别为1390.94%、1116.23%、913.93%,振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 ,振幅分别为224.93%、87.83%、66.67%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226003246abdc9ada&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226003246abdc9ada&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALT","LU1878469433.USD","BK4599"],"gpt_icon":0},{"id":"2513720245","title":"Altimmune, Inc.盘中异动 快速跳水5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720245?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:02","pubTimestamp":1740409376,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时02分,Altimmune, Inc.股票出现异动,股价大幅下挫5.02%。截至发稿,该股报6.11美元/股,成交量30.6286万股,换手率0.43%,振幅5.19%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.24%。其相关个股中,Pepgen Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Avalo Therapeutics, Inc.涨幅较大,Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃,换手率分别为156.69%、69.94%、25.47%,振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ,振幅分别为137.23%、55.69%、41.14%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230256a2521c30&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224230256a2521c30&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","LU1878469433.USD","BK4599","BK4139"],"gpt_icon":0},{"id":"2512193805","title":"Altimmune, Inc.盘中异动 大幅拉升5.02%报6.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512193805","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512193805?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:53","pubTimestamp":1739901219,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时53分,Altimmune, Inc.股票出现波动,股价快速拉升5.02%。截至发稿,该股报6.69美元/股,成交量143.045万股,换手率2.01%,振幅5.02%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.66%。其相关个股中,Aditxt, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Allogene Therapeutics, Inc.涨幅较大,Aditxt, Inc.、Moleculin Biotech, Inc.、Solid Biosciences Inc.较为活跃,换手率分别为594.05%、191.57%、161.21%,振幅较大的相关个股有Estrella Immunopharma Inc C/Wts 29/09/2028、Abvc Biopharma, Inc.、Allogene Therapeutics, Inc.,振幅分别为148.75%、92.00%、79.17%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219015340a24ad74f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219015340a24ad74f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","LU1878469433.USD","BK4139","BK4599"],"gpt_icon":0},{"id":"2510338592","title":"Altimmune, Inc.盘中异动 早盘股价大跌5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510338592","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510338592?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:41","pubTimestamp":1739284873,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时41分,Altimmune, Inc.股票出现异动,股价大幅下挫5.29%。截至发稿,该股报6.26美元/股,成交量19.2329万股,换手率0.27%,振幅3.48%。Altimmune, Inc.股票所在的生物技术行业中,整体跌幅为1.30%。其相关个股中,Dominari Holdings Inc.、Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为2242.92%、592.17%、230.89%,振幅较大的相关个股有Ocean Biomedical, Inc.、In8Bio, Inc.、Dominari Holdings Inc.,振幅分别为33.04%、31.80%、29.38%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112241149881befc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112241149881befc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","LU1878469433.USD","ALT","BK4139"],"gpt_icon":0},{"id":"2509244146","title":"疑似AltLayer新多签地址从CEX提取3.99亿枚ALT,约合1982万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509244146","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509244146?lang=zh_cn&edition=full","pubTime":"2025-02-06 17:10","pubTimestamp":1738833022,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://x.com/OnchainLens/status/1887427368836604130","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4139","BK4599","ALT","LU1878469433.USD"],"gpt_icon":0},{"id":"2509280019","title":"Altimmune, Inc.盘中异动 股价大涨5.12%报6.98美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509280019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509280019?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:23","pubTimestamp":1738769008,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时23分,Altimmune, Inc.股票出现异动,股价大幅上涨5.12%。截至发稿,该股报6.98美元/股,成交量30.8819万股,换手率0.43%,振幅4.37%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为1.45%。其相关个股中,Oragenics Inc.、Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大,Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为3932.53%、1159.54%、674.29%,振幅较大的相关个股有Oragenics Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Scisparc Ltd.,振幅分别为59.80%、54.05%、41.46%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205232329961912d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205232329961912d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALT","BK4599","LU1878469433.USD","BK4139"],"gpt_icon":0},{"id":"2508497481","title":"Altimmune, Inc.盘中异动 早盘急速下跌5.42%报6.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508497481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508497481?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:35","pubTimestamp":1738593345,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时35分,Altimmune, Inc.股票出现异动,股价快速下跌5.42%。截至发稿,该股报6.28美元/股,成交量13.3915万股,换手率0.19%,振幅1.05%。Altimmune, Inc.股票所在的生物技术行业中,整体跌幅为0.36%。其相关个股中,Hcw Biologics Inc.、Gh Research Plc、Briacell Therapeutics Corp.涨幅较大,Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃,换手率分别为353.88%、307.70%、144.53%,振幅较大的相关个股有Hcw Biologics Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Invivyd, Inc.,振幅分别为57.23%、33.33%、27.90%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322354598796fb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020322354598796fb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","ALT","BK4599","BK4139"],"gpt_icon":0},{"id":"2508943789","title":"Altimmune, Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508943789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508943789?lang=zh_cn&edition=full","pubTime":"2025-02-01 03:47","pubTimestamp":1738352870,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日03时47分,Altimmune, Inc.股票出现波动,股价急速跳水5.00%。截至发稿,该股报6.65美元/股,成交量129.71万股,换手率1.82%,振幅5.54%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.55%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Metsera, Inc.、Cyclerion Therapeutics, Inc.涨幅较大,Cyclerion Therapeutics, Inc.、Nls Pharmaceutics Ltd.、Silexion Therapeutics Corp较为活跃,换手率分别为2782.24%、2045.11%、205.46%,振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Seastar Medical Holding Corporation,振幅分别为121.11%、80.00%、69.36%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020103475096150f48&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025020103475096150f48&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1878469433.USD","BK4599","ALT"],"gpt_icon":0},{"id":"2503642251","title":"Altimmune, Inc.盘中异动 早盘股价大涨6.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503642251","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503642251?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:31","pubTimestamp":1736951471,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时31分,Altimmune, Inc.股票出现异动,股价急速上涨6.18%。截至发稿,该股报6.62美元/股,成交量12.7942万股,换手率0.18%,振幅0.90%。Altimmune, Inc.股票所在的生物技术行业中,整体涨幅为0.68%。其相关个股中,Os Therapies Incorporated、Generation Bio Co.、Exicure, Inc.涨幅较大,Windtree Therapeutics, Inc.、Os Therapies Incorporated、Phio Pharmaceuticals Corp.较为活跃,换手率分别为184.25%、56.33%、51.74%,振幅较大的相关个股有Os Therapies Incorporated、Klotho Neurosciences, Inc.、Vincerx Pharma, Inc.,振幅分别为18.99%、12.00%、10.72%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522311298673ac4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011522311298673ac4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","BK4599","BK4139","ALT"],"gpt_icon":0},{"id":"2503577489","title":"Altimmune, Inc.盘中异动 早盘股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503577489","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503577489?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:57","pubTimestamp":1736866668,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时57分,Altimmune, Inc.股票出现波动,股价快速下挫5.01%。Altimmune, Inc.股票所在的生物技术行业中,整体跌幅为0.38%。其相关个股中,Eterna Therapeutics Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大,Soligenix, Inc.、Phio Pharmaceuticals Corp.、Eterna Therapeutics Inc.较为活跃,换手率分别为379.07%、344.35%、329.12%,振幅较大的相关个股有Eterna Therapeutics Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为110.06%、50.00%、34.18%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114225748986607ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114225748986607ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","ALT","BK4139","LU1878469433.USD"],"gpt_icon":0},{"id":"2502862318","title":"Altimmune, Inc.盘中异动 早盘股价大跌5.03%报7.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502862318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502862318?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:32","pubTimestamp":1736519528,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时32分,Altimmune, Inc.股票出现波动,股价大幅下跌5.03%。截至发稿,该股报7.08美元/股,成交量15.0704万股,换手率0.21%,振幅1.95%。Altimmune, Inc.股票所在的生物技术行业中,整体跌幅为0.83%。其相关个股中,Precision Biosciences, Inc.、Conduit Pharmaceuticals Inc.、Zyversa Therapeutics, Inc.涨幅较大,Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃,换手率分别为901.72%、131.67%、105.87%,振幅较大的相关个股有Zyversa Therapeutics, Inc.、Precision Biosciences, Inc.、Conduit Pharmaceuticals Inc.,振幅分别为15.25%、10.00%、8.90%。Altimmune, Inc.公司简介:Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011022320995ff6cf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011022320995ff6cf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","ALT","BK4599","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.altimmune.com","stockEarnings":[{"period":"1week","weight":0.0346},{"period":"1month","weight":-0.1756},{"period":"3month","weight":-0.2987},{"period":"6month","weight":-0.2872},{"period":"1year","weight":-0.3068},{"period":"ytd","weight":-0.3356}],"compareEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":-0.0888},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.1109},{"period":"1year","weight":0.0378},{"period":"ytd","weight":-0.1232}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Altimmune, Inc.于2005年4月25日根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司,专注于开发肥胖和肝脏疾病的治疗方法。公司的主要候选产品pemvidutide(原名ALT-801)是一种GLP-1/胰高血糖素双受体激动剂,正在开发用于治疗肥胖和代谢功能障碍相关的脂肪性肝炎(“MASH”),以前称为非酒精性脂肪性肝炎(“NASH”)。","yearOnYearQuotes":[{"month":1,"riseRate":0.388889,"avgChangeRate":-0.008115},{"month":2,"riseRate":0.388889,"avgChangeRate":0.000059},{"month":3,"riseRate":0.388889,"avgChangeRate":-0.052418},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.054747},{"month":5,"riseRate":0.470588,"avgChangeRate":0.065968},{"month":6,"riseRate":0.411765,"avgChangeRate":0.016734},{"month":7,"riseRate":0.411765,"avgChangeRate":0.04705},{"month":8,"riseRate":0.411765,"avgChangeRate":0.108003},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.121386},{"month":10,"riseRate":0.222222,"avgChangeRate":0.030284},{"month":11,"riseRate":0.388889,"avgChangeRate":-0.02446},{"month":12,"riseRate":0.555556,"avgChangeRate":0.21194}],"exchange":"NASDAQ","name":"Altimmune, Inc.","nameEN":"Altimmune, Inc."},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Altimmune, Inc.(ALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Altimmune, Inc.,ALT,Altimmune, Inc.股票,Altimmune, Inc.股票老虎,Altimmune, Inc.股票老虎国际,Altimmune, Inc.行情,Altimmune, Inc.股票行情,Altimmune, Inc.股价,Altimmune, Inc.股市,Altimmune, Inc.股票价格,Altimmune, Inc.股票交易,Altimmune, Inc.股票购买,Altimmune, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Altimmune, Inc.(ALT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Altimmune, Inc.(ALT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}